Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.

In real-life practice, the introduction of BBCF allows significant and clinically meaningful IOP reduction and therapy simplification in glaucoma patients requiring complex medication, but in more than one third of the patients it is not tolerated due to adverse events.